Methionine, cysteine, homocysteine, and taurine are the 4 common sulfur-containing amino acids, but only the first 2 are incorporated into proteins. Sulfur belongs to the same group in the periodic table as oxygen but is much less electronegative
3. • Methionine-is an essential amino acid
• Sulphur containing amino acid
• Glucogenic amino acid in nature
• Methionine degrades to cysteine synthesis
Metabolism of S containing amino acids:
1. Activation of methionine to SAM:
• In the major pathway, methionine is activated to
‘active methionine’ or SAM
• Adenosyl group is transferred to S atom
3
6. • Methyl transfer: Methionine has a very stable -
THIO-ETHER LINKAGE (C-S-C)
2. In SAM (S-Adenosyl Methionine) there is a high
energy bond, methyl group can be transferred
to other acceptors. SAM gets converted to S-
adenosyl homocysteine (SAH)
3. Homocysteine Formation:
SAH
Adenosine homocysteinase Adenosyl group
Homocysteine (HCys)
6
9. 5. Cysteine synthesis: Cystathionine is hydrolysed
by cystathionase to form cysteine and
homoserine.
• Net result is- SH group from methionine is
transferred to serine to form cysteine. This is
called trans-sulfuration reaction.
6. Final oxidation: Homoserine is deaminated &
then decarboxylated to propionyl CoA.
• Enters TCA cycle as succinyl CoA or
• Forms Glucose by Gluconeogenesis
9
10. Role of Met in Transmethylation Reactions
Some important products formed are…
-- Creatine *Reactions of Methyl
groups transfer;
derived
-- Epinephrine from 1 C pool
-- Choline *SAM
10
13. • Methyl THF can transfer the methyl group only to
homocysteine (HCys) in the presence of Vitamin B12
as co-enzyme
• Vitamin B12 deficiency accounts to the deficiency of
folate too, called the
• “FOLATE TRAP”.
• SAM is the methyl donor for all the
trans methylation reactions.
13
16. • Cysteine is non-essential amino acid
• Glucogenic in nature
• Cysteine is present in keratin of hair & nails
• Formation of cysteine is by using the carbon skeleton
contributed by serine and sulphur from methionine.
Met SAM SAH HCY+ Ser Cysteine
16
17. Degradation of Cysteine
• Transamination: Cysteine transaminates to form
beta mercapto pyruvic acid and finally pyruvate.
The sulphur may be removed either as H2S/
elemental sulphur
• Cysteine on decarboxylation gives beta mercapto
ethanolamine. This is used for synthesis of co-
enzyme A after combining with pantothenic acid
and phosphate.
17
20. Metabolic Functions of Cysteine
A. Formation of Glutathione
• Glutathione is gamma-glutamyl cysteinyl glycine.
It is generally abbreviated as GSH, to indicate SH
group.
Glutamate + Cysteine Gamma-glutamyl cysteine
Gamma glutamyl cysteine Glutathione
• Both steps need hydrolysis of each ATP.
1. Role of GSH in amino acid transport :
Glutathione is involved in the absorption of amino
acid.
20
21. 3. Co-enzyme Role
• Metabolic role of GSH is mainly in reduction
reactions.
2GSH GS-SG + H2
• The hydrogen released is used for reducing other
substrates…..
Maleyl acetoacetate Fumaryl acetoacetate
Cysteic acid Taurine
21
22. 4. RBC Membrane Integrity
• Glutathione is present in the RBCs which inactivates
free radicals formed inside RBC by the action of
Glutathione peroxidase, a selenium containing
enzyme.
• Glutathione is regenerated by an NADPH dependent
glutathione reductase. (NADPH is derived from the
HMP shunt pathway)
• The occurence of hemolysis in G6PD deficiency is
attributed to the decreased regeneration of reduced
glutathione.
22
23. 5. Met- hemoglobin
• The met-Hb is unavailable for oxygen transport.
• Glutathione is necessary for the reduction of met-
hemoglobin (ferric state) to normal Hb (ferrous state).
2Met-Hb-(Fe+3) + 2GSH 2Hb-(Fe+2) + 2H+ + GS-SG
6. Conjugation for Detoxification
• Glutathione helps to detoxify several compounds by
transferring the cysteinyl group, e.g. --
Organophosphorus compounds
-- Heavy metals
-- Drug metabolism
23
24. 7. Activation of Enzymes
• Many enzymes having SH groups in the active site
are kept in the active form by the glutathione.
• Such enzymes are active in the reduced form.
Glutathione keeps enzymes in reduced, active
state.e.g.Glyceraldehyde-3-P-dehydrogenase.
24
26. B. Formation of Taurine From cysteine
• Cysteine is oxidised to form taurine.
• Alternatively cysteine is oxidised to cysteine
sulfinic acid, decarboxylated by a decarboxylase to
hypotaurine which in turn is oxidised to taurine.
• Taurine is used for conjugation of bile acids.
Taurine+Cholyl CoA Taurocholate+CoA-SH
• Taurine is a modulator of calcium fluxes, calcium
binding and movement.
• In CNS it is an inhibitory neurotransmitter.
26
27. C. Keeping the Correct structure of Proteins
• Cysteine residues in polypeptide chains form
disulfide bridges to make active proteins, e.g.
insulin and immunoglobulins. Protein disulfide
isomerase forms these disulfide bonds.
27
28. METABOLISM OF SULPHUR
• The S present in body may be either organic sulphur
as a component of proteins/as sulfatides and
glycosamino glycans (GAG).
• Inorganic sulfur is derived from the sulfur
containing amino acids by trans-sulfuration or
desulfuration reactions.
• The excretory forms of sulphur in urine are
Inorganic sulfates, Organic or ethereal sulfates and
Neutral sulfur.
28
29. Formation of Active Sulfate
• Active sulfate or phospho adenosine phospho-5’-
sulfate (PAPS) is formed by the reaction between
ATP and SO4 and the sulfate is attached to the
ribose-5’-phosphate.
• PAPS is used for various sulfuration reactions, e.g.
synthesis of sulfatides,GAG
2ATP + SO4 PAPS + ADP + PPi
29
30. Cystinuria
• It is an autosomal recessive condition.
• This is mainly because of deficiency in renal
transport defect in that reabsorption of these
amino acids do not occur.
• Signs and symptoms include:
-- Chief abnormality is the excretion of cysteine and to
a lesser extent lysine, ornithine and arginine.
-- Crystalluria: In acidic pH, cystine crystals are
formed in urine, form calculi (stones).
30
31. Cyanide-nitroprusside Test
• It is a screening test.
• Urine is made alkaline with ammonium hydroxide
and sodium cyanide is added.
• Cystine, if present, is reduced to cysteine. Then
add sodium nitroprusside to get a magenta-red
coloured complex. The intensity of colour is
proportional to free –SH content.
• Specific aminoaciduria may be confirmed by
chromatography.
31
32. Cystinosis (Cystine storage disease)
• Deposition of cystine crystals in lysosomes.
• Cystine accumulates in liver, spleen, bone marrow, WBC,
kidneys, cornea and lymph nodes.
• There is an abnormality in transport of cysteine which is
responsible for the accumulation.
• There may also be an impaired conversion of cystine to
cysteine due to lack of cystine reductase enzyme.
• It is an autosomal recessive condition. Microscopy of blood
shows cystine crystals in WBCs.
32
33. HOMOCYSTINURIAS
• Normal homocysteine in blood is 5-15 micro mol/L
• In diseases, it may be increased to 50-100 times
Moderate increase is seen in aged persons, vitamin B12
or B6 deficiency, tobacco smokers, alcoholics and in
hypothyroidism.
• Large amounts of homocysteine excreted in urine.
• In plasma, homocysteine (with –SH group) and
homocystine (disulphide, S-S group) exist.
• Both of them are absent in normal urine; but if present,
it will be the homocystine (disulphide).
33
34. • If homocysteine level in blood is increased, there is
increased risk for coronary artery diseases.
• It increases the possibility of thrombosis, and also
plaque formation, so damaging the arteries.
• An insufficient concentration of folic acid, vitamin B12
and pyridoxine also increase the homocysteine levelin
blood.
• An increase of 5 micromol/L of homocysteine in serum
elevates the risk of coronary artery disease by as much
as cholesterol increase of 20 mg/dl.
34
35. Causes of congenital homocystinurias:
1. Cystathionine Beta Synthase Deficiency (Classical or
type 1)
• Elevated plasma level of methionine &
homocysteine.Plasma Cys is markedly reduced.
• Excretion of Met & homocystine in urine is more
• General symptoms are mental retardation and
Charley Chaplin gait (long extremities with flat
feet and toes out). Skeletal deformities are seen.
• In eyes, ectopia lentis, myopia and glaucoma may
be observed.
35
37. • Homocysteine causes activation of Hageman’s factor.
This may lead to increased platelet adhesiveness and
life-threatening intravascular thrombosis.
• Cyanide-nitroprusside test will be positive in urine.
Urinary excretion of homocystine is more than 300
mg/24h. Plasma homocysteine and methionine levels
are increased.
• Treatment is a diet low in methionine and rich in
cysteine. Sometimes the affinity of apo-enzyme to the
co-enzyme is reduced. In such cases, pyridoxal
phosphate, the co-enzyme given in large quantities
(500 mg) will correct the defect.
37
38. 2.Cobalamin Deficiency
• The enzyme, N5-methyl-THFA-homocysteine-
methyl-transferase is dependent on vitamin B12.
So, B12 deficiency may produce alteration in
methionine metabolism.
• Blood contains increased level of homocysteine,
but methionine level is low.
• Urine contains homocystine.
38
40. 3. Deficient N5,N10-Methylene THFA Reductase
• This enzyme catalyses the reaction N5, N10-
methylene-THFA to N5-methyl-THFA.
• Deficiency of this enzyme leads to reduced
methionine synthesis with consequent increase in
homocystine level in urine.
• Behavioral changes and vascular abnormalities
may be observed.
• Folate supplementation is beneficial.
40
41. 4. Cystathioninuria
• It is due to cystathionase deficiency. It is an
autosomal recessive condition.
• Mental retardation, anemia, thrombocytopenia,
and endocrinopathies accompany this condition.
• Acquired Cystathioninuria may be due to
pyridoxine deficiency.
41
42. 5. Acquired hyper-homocysteinemias
• Nutritional deficiency of vitamins, such as
cobalamine, folic acid and pyridoxine.
• Metabolic : Chronic renal diseases,
hypothyrodism.
• Drug induced: Folate antagonists, vitamin B12
antagonists, nitric oxide antagonists.
42